عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Suppressing COVID-19 Transmission 19/7/2020


          
       Measures Taken by MoPH to Suppress COVID-19            Measures Taken by the Government and Other Ministries


          
       Travel Restrictions and Social Distancing Measures                    Cumulative Number of COVID-19 Positive Cases 19/7/2020


         
MoPH, General Directorate                                                              Cumulative Number of COVID-19 Positive Cases 19/7/2020 


          
                  Number of COVID-19 tests - 19/7/2020                                                           COVID-19-Lebanon-19/7/2020 


         
COVID-19 New Cases-19/7/2020                                                          MoPH Strategy


    1
    ...
    143
    144
    145
    146
    147
    148
    ...
    187
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
N05AH03 8 G O scored" 209 L.L
N03AX09 2 B L 741 209" 23.08 B 3/10/2025 L.L
B03XA01 9 Bio 000IU" 1 210 L.L
B05BB02 2 G " H2O - 5 210" 16.67 3/10/2025 L.L
L01FA01 2 Bio 761 210" 2.44 E2 3/10/2025 L.L
R03AK07 1 B " 689 210" 23.08 B 3/10/2025 L.L
N07XX02 1 B R 886 212" 19.35 D 3429 Sanofi Mature IP France 3/10/2025 L.L
N07XX02 1 B R 886 212" 19.35 D 347 Sanofi Winthrop Industrie France 3/10/2025 L.L
N07XX02 1 B R 886 212" 19.35 D 826 Aventis Pharma SA France 3/10/2025 L.L
C10AA05 2 G A 263 212" 23.08 A2 1929 Sandoz Pharmaceuticals AG Switzerland 3/10/2025 L.L
B02BD04 1 Bio 506 214" 19.35 D 990 Baxter AG Austria 3/10/2025 L.L
J05AB11 1 G V 318 214" 23.08 B 3/10/2025 L.L
D10AD53 2 B " 201 214" 23.08 B 1223 Galderma International France 3/10/2025 L.L
J01CR05 2 B " 306 215" 23.08 A2 830 Pfizer Ltd UK 3/10/2025 L.L
L01EF01 1 B P 164 216" 2.44 E2 2783 Pfizer Europe MA EEIG Belgium 3/10/2025 L.L
L01EF01 2 B P 164 216" 2.44 E2 2783 Pfizer Europe MA EEIG Belgium 3/10/2025 L.L
L01EF01 3 B P 164 216" 2.44 E2 2783 Pfizer Europe MA EEIG Belgium 3/10/2025 L.L
G04BE08 2 G T 574 216" 23.08 B 3/10/2025 L.L
C10BA05 1 G " film co 219" 23.08 A1 1038 Marcyrl Pharmaceuticals Industries (MPI) Egypt 3/10/2025 L.L
C09DB01 1 G " coated" 220" 23.08 A2 738 Arrow Génériques France 3/10/2025 L.L
C09DB01 2 G " coated" 220" 23.08 A2 738 Arrow Génériques France 3/10/2025 L.L
L01EF01 1 G P 011 222" 2.44 E2 3/10/2025 L.L
L01EF01 2 G P 011 222" 2.44 E2 3/10/2025 L.L
H01CB02 2 B O 121 223" 10.71 E1 283 Novartis Pharma AG Switzerland 3/10/2025 L.L
L04AA31 1 G T 451 224" 10.71 E1 3/10/2025 L.L
L01EC03 2 Bio LLC" US 227 L.L
B06AC05 1 Bio 204 227 L.L
H01BB03 1 G C 041 227" 21.26 C 2963 "GP-Pharm L.L
C04AD03 2 G P 478 227" 23.08 B 3579 AA Pharma Inc. Canada 3/10/2025 L.L
N05AH04 4 G Q 947 228" 23.08 B 3036 Neuraxpharm Spain SLU Spain 3/10/2025 L.L
    1
    ...
    143
    144
    145
    146
    147
    148
    ...
    187
Sitemap
© Copyrights reserved to Ministry of Public Health 2025